Discovery of compound 1105486 as a selective inhibitor of B4GALT1: potential for pancreatic cancer therapy.

Front Chem · 2025 · PMC12375551 · PMID 40860122

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Statistical analysis confirmed that these effects were highly significant for cancer versus normal cells at relevant concentrations.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.